Position in DXCM
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$6,735
+$6,732 QoQ
Shares Held
100
+400.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#862
of 971 holders
Holding Since
Mar 2020
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Bollard Group LLC holds $794,196,737 across 7 Medical Devices names. DXCM ranks #5 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
18,420,720 | $786,196,329 | |
| 2 | ABT |
Abbott Laboratories
|
80,925 | $7,343,134 | |
| 3 | MDT |
Medtronic plc
|
4,253 | $332,712 | |
| 4 | SYK |
Stryker Corp
|
992 | $312,321 | |
| 5 | DXCM |
Dexcom Inc
This page
|
100 | $6,735 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
86 | $5,504 | |
| 7 | MYO |
Myomo, Inc.
|
1,570 | $2 |
All Filings in DXCM
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,735 | 100 | Shares | Defined | 2026-08-12 | |
| 2023-06-30 | $3 | 20 | Shares | Defined | 2023-08-14 | |
| 2020-09-30 | $164,892 | 400 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $162,160 | 400 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $53,854 | 200 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||